The effect of oxyntomodulin (Glucagon-37) and glucagon on exocrine pancreatic secretion in the conscious rat
- 1 November 1987
- Vol. 8 (6), 967-972
- https://doi.org/10.1016/0196-9781(87)90122-7
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Somatostatin enhances the inhibitory effect of oxyntomodulin and its C-terminal octapeptide on acid secretionPeptides, 1986
- The biological significance of “Enteroglucagon”. Present statusPeptides, 1986
- Oxyntomodulin (glucagon-37) and its C-terminal octapeptide inhibit gastric acid secretionFEBS Letters, 1985
- Isolation of glucagon‐37 (bioactive enteroglucagon/oxyntomodulin) from porcine jejuno‐ileumFEBS Letters, 1982
- Isolation of glucagon‐37 (bioactive enteroglucagon/oxyntomodulin) from porcine jejuno‐ileumFEBS Letters, 1982
- Oxyntomodulin (glucagon-37 or bioactive enteroglucagon): A potent inhibitor of pentagastrin-stimulated acid secretion in ratsBioscience Reports, 1982
- ‘Enteroglucagon’: A specific effect on gastric glands isolated from the rat fundus. Evidence for an ‘oxyntomodulin’ actionBioscience Reports, 1981
- Effect of glucagon on the secretory process in the rat exocrine pancreasCell and tissue research, 1977
- Inhibitory Activity of Glucagon on Caerulein Exocrine Stimulation, Independent of HyperglycemiaPublished by Springer Nature ,1972
- Effect of Glucagon on Gastric Secretion in the DogGut, 1960